A Phase III Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid in Patients with Hyperlipidemia Not Adequately Controlled by Statins
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
This trial is a phase III study to evaluate the efficacy , tolerability, and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• 1\. 18 years and older, male or female.
• 2\. 18 kg/m2 ≤Body Mass Index (BMI) ≤35 kg/m2.
• 3\. Participants must agree to use reliable contraception from the screening day until 30 days after the last dose, and must not donate sperm or eggs for assisted reproduction purposes.
• 4\. Fully understand the purpose and requirements of the study, voluntarily participate in the clinical trial, and sign a written informed consent form, capable of completing the entire study process.
Locations
Other Locations
China
Site 01
RECRUITING
Beijing
Contact Information
Primary
Wei Zhao
wei.zhao@ganlee.com
010-56456726
Time Frame
Start Date: 2024-12-20
Estimated Completion Date: 2025-10
Participants
Target number of participants: 240
Treatments
Experimental: Bempedoic acid
Once daily
Placebo_comparator: Placebo
Once daily
Related Therapeutic Areas
Sponsors
Leads: Gan & Lee Pharmaceuticals.